Alnylam Pharmaceuticals, Inc (NASDAQ:ALNY) Q4 2020 Earnings Conference Call February 11, 2021 8:30 AM ET Company Participants Christine Lindenboom - Senior Vice President of Investor Relations & Corporate Communications John Maraganore - Chief Executive Officer Tolga Tanguler - Chief Commercial Officer Akshay Vaishnaw - President, Resarch & Development Jeff Poulton - Chief Financial Officer Yvonne Greenstreet - President & Chief Operating Officer Andy Orth - Senior Vice President & Head of US Business Confe ...

Alnylam Pharmaceuticals, Inc (NASDAQ:ALNY) Q3 2020 Earnings Conference Call November 5, 2020 8:30 AM ET Company Participants Christine Lindenboom - Senior Vice President of Investor Relations & Corporate Communications John Maraganore - Chief Executive Officer Andy Orth - Senior Vice President & Head of US Business Akshay Vaishnaw - President of Resarch & Development Jeff Poulton - Chief Financial Officer Yvonne Greenstreet - President & Chief Operating Officer Conference Call Participants Gena Wang - Barcl ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________ FORM 10-Q ____________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission File Number 001-36407 _______________ ...

Alnylam Pharmaceuticals, Inc (NASDAQ:ALNY) Q2 2020 Results Conference Call August 6, 2020 8:30 AM ET Company Participants Christine Lindenboom - Senior Vice President of Investor Relations John Maraganore - Chief Executive Officer Barry Greene - President Akshay Vaishnaw - President of R&D Jeffrey Poulton - Chief Financial Officer Yvonne Greenstreet - Chief Operating Officer Andy Orth - Head of the U.S. Business Conference Call Participants Paul Matteis - Stifel Nicolaus Alethia Young - Cantor Fitzgerald A ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________ FORM 10-Q ____________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission File Number 001-36407 ____________________ ...

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2020 Earnings Conference Call May 5, 2020 10:00 AM ET Company Participants Christine Lindenboom - VP, IR and Corporate Communications John Maraganore - CEO Barry Greene - President Akshay Vaishnaw - President of R&D Jeff Poulton - Chief Financial Officer Yvonne Greenstreet - Chief Operating Officer Conference Call Participants David Lebowitz - Morgan Stanley Tazeen Ahmad - Bank of America Paul Matteis - Stifel Anupam Rama - JP Morgan Ritu Baral - Cowen Salveen ...